Reply to letter to the editor on "Intravenous versus intra-articular tranexamic acid in total knee arthroplasty: A double-blinded randomised controlled noninferiority trial"

Knee. 2017 Jun;24(3):700-701. doi: 10.1016/j.knee.2016.07.006. Epub 2017 Feb 16.

Authors

Jerry Yongqiang Chen¹, Pak Lin Chin², Ing How Moo², Hee Nee Pang², Darren Keng Jin Tay², Shi-Lu Chia², Ngai Nung Lo², Seng Jin Yeo²

Affiliations

¹ Department of Orthopaedic Surgery, Singapore General Hospital, Singapore. Electronic address: [email protected].
² Department of Orthopaedic Surgery, Singapore General Hospital, Singapore.

PMID: 28215979
DOI: 10.1016/j.knee.2016.07.006

No abstract available

Publication types

Letter
Comment

MeSH terms

Administration, Intravenous
Antifibrinolytic Agents
Arthroplasty, Replacement, Knee*
Blood Loss, Surgical
Blood Transfusion
Humans
Injections, Intra-Articular
Postoperative Hemorrhage
Tranexamic Acid*

Substances

Antifibrinolytic Agents
Tranexamic Acid